Revenues, net income increase in third quarter for Regeneron

Regeneron reported total revenues of $1.2 billion in the third quarter compared with $1.1 billion in the third quarter of 2015, an increase of 7%, according to a press release.This included $857 million in net product sales from Eylea (aflibercept), an increase from $738 million in the third quarter of last year.